Three-Part Pressure-Sensitive Adhesive for Transdermal Drug Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Pressure-sensitive adhesives (PSAs) used in transdermal drug delivery systems face challenges in achieving strong bonding characteristics while maintaining compatibility with the skin and drugs, and existing PSAs may not be effective in water exposure scenarios.

Innovation Solution

Development of pressure-sensitive adhesive polymers (PSAs) with a three-part structure, comprising skin-mimicking monomers, weakly hydrophilic monomers, and hydrophobic monomers, which form hydrogen bonds with skin lipids for strong adhesion and include a hydrophobic portion to prevent water penetration, ensuring adhesion even in wet conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If PSAs are designed to achieve strong bonding characteristics, then adhesion strength is improved, but compatibility with skin and drugs may deteriorate

Engineering Contradiction:
Improveadhesion strengthVSAvoidcompatibility with skin and drugs
Core Design Contradiction:
StrengthVSAdaptability or versatility

Solution Approach 1:

The patent applies local quality by creating a PSA with distinct functional regions: a skin-mimicking portion with polar groups for strong skin adhesion, a hydrophilic portion for drug compatibility, and a hydrophobic portion for water resistance. Each portion has optimized local properties to fulfill specific functions while working together as an integrated adhesive system.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs composite materials by combining multiple monomer types (skin-mimicking monomers with polar groups, hydrophilic monomers, and hydrophobic monomers) into a single PSA polymer structure. This composite approach allows the adhesive to simultaneously exhibit strong bonding, skin compatibility, drug compatibility, and water resistance that cannot be achieved with a single homogeneous material.

Inventive Principle:
Principle #40Composite materials

2Strength

If PSAs are designed for strong adhesion to skin, then bonding characteristics are improved, but effectiveness in water exposure conditions deteriorates

Engineering Contradiction:
Improvebonding characteristicsVSAvoideffectiveness in water exposure
Core Design Contradiction:
StrengthVSReliability

Solution Approach 1:

The patent applies local quality by incorporating a hydrophobic portion within the PSA structure specifically to address water exposure conditions. This hydrophobic region repels water and prevents water from interfering with the skin-mimicking portion's bonding to the skin, thereby maintaining adhesive effectiveness in wet environments.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs composite materials by integrating hydrophobic monomers into the PSA polymer alongside skin-mimicking and hydrophilic monomers. This composite structure creates a multi-functional adhesive that maintains strong bonding to skin while simultaneously resisting water penetration and maintaining reliability in water exposure conditions.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The three-part structured PSAs provide strong and durable adhesion to the skin, remaining effective even when exposed to water, reducing water penetration and maintaining adhesion properties, thus enhancing the performance of transdermal drug delivery systems.

Implementation Method 1

form hydrogen bonds with skin lipids for strong adhesion

Methodology Applied
Scientific EffectHydrogen bonding: Chemical Bonding

Implementation Method 2

include a hydrophobic portion to prevent water penetration

Methodology Applied
Scientific EffectHydrophobic effect: Hydrophobe

Data Source

PatentUS10406115B2Pressure-sensitive adhesives for transdermal drug delivery
Publication Date: 2019.09.10 NOVEN PHARMACEUTICALS INC
  • US10406115B2 patent drawing
  • US10406115B2 patent drawing
  • US10406115B2 patent drawing

AI summary

Described are pressure-sensitive adhesive polymers (PSAs) useful, for example, for application to the skin, such as in the field of transdermal drug delivery. The PSAs include polar groups modeled on one or more polar portions of skin lipids, which contribute to good skin adhesion properties. Methods of making the PSAs, compositions comprising them, and methods of making and using them also are provided.